Specifically, we consider contributions of both central and peripheral GLP-1 and propose an integrated model of short-term and long-term control of energy balance
But it also leads me to wanting to say its interesting, because if that had been our motivation to actually say, oh, there's weight loss in diabetes, let's pursue it in people with obesity, I don't think we would've done that because the weight loss in people with diabetes wasn't that impressive
Adherence was calculated through the medication possession ratio (MPR) [26]
In addition to molecular modulation, ketone bodies contribute to the brains bioenergy, which could support cognitive abilities
5 By neutralizing myostatin before it reaches its receptors, trevogrumab effectively removes this constraint, allowing the body to preserve (and potentially build) muscle even during the caloric deficit created by GLP-1 drugs
And, more importantly, are they even safe to use